{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:29:30Z","timestamp":1777087770751,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["K108631"],"award-info":[{"award-number":["K108631"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.026","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T06:30:47Z","timestamp":1542868247000},"page":"99-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary"],"prefix":"10.1016","volume":"37","author":[{"given":"Eszter","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Sahin-T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienn","family":"T\u00f3thp\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Krist\u00f3f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Tirczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-2288","authenticated-orcid":false,"given":"Orsolya","family":"Dobay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.026_b0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2018.11.026_b0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"Suppl S2","key":"10.1016\/j.vaccine.2018.11.026_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/dkf511","article-title":"From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae","volume":"50","author":"De Lencastre","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2018.11.026_b0020","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JCM.36.12.3514-3519.1998","article-title":"Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing","volume":"36","author":"Shi","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.026_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species","volume":"32","author":"Pletz","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2018.11.026_b0030","first-page":"141","article-title":"Pneumococcal vaccination in Europe","volume":"16","author":"National Center for Epidemiology","year":"2009","journal-title":"Epinfo"},{"key":"10.1016\/j.vaccine.2018.11.026_b0035","unstructured":"National Center for Epidemiology. Methodological letter of the National Center for Epidemiology about the vaccines in 2014. Epinfo. 2014; 21 (special issue) [in Hungarian]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0040","first-page":"487","article-title":"Pneumococcal vaccination data in Hungary as in August 2009","volume":"16","author":"National Center for Epidemiology","year":"2009","journal-title":"Epinfo"},{"key":"10.1016\/j.vaccine.2018.11.026_b0045","first-page":"369","article-title":"Accomplishment of vaccines in 2015","volume":"23","author":"National Center for Epidemiology","year":"2016","journal-title":"Epinfo"},{"key":"10.1016\/j.vaccine.2018.11.026_b0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/48.6.915","article-title":"Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants","volume":"48","author":"Nagai","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2018.11.026_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diagmicrobio.2016.03.018","article-title":"lytA-based identification methods can misidentify Streptococcus pneumoniae","volume":"85","author":"Sim\u00f5es","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0060","unstructured":"Centers for Disease Control and Prevention. List of oligonucleotide primers used in 41 conventional multiplex PCR assays for pneumococcal serotype deduction of 71 serotypes. https:\/\/www.cdc.gov\/streplab\/downloads\/pcr-oligonucleotide-primers.pdf; 2014 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0065","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/JCM.41.6.2378-2384.2003","article-title":"Serotyping Streptococcus pneumoniae by multiplex PCR","volume":"41","author":"Brito","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.026_b0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1469-0691.2005.01197.x","article-title":"The relationship between serotypes and PFGE genotypes in isolates of Streptococcus pneumoniae from Hungary","volume":"11","author":"Dobay","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.11.026_b0075","unstructured":"Streptococcus pneumoniae MLST website. https:\/\/pubmlst.org\/spneumoniae\/; 2010 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0080","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1017\/S0950268815002757","article-title":"Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination","volume":"144","author":"T\u00f3thp\u00e1l","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.11.026_b0085","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 8.0. http:\/\/www.eucast.org\/clinical_breakpoints\/; 2018 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijantimicag.2005.02.010","article-title":"Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene","volume":"25","author":"Dobay","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2018.11.026_b0095","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.11.026_b0100","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.43.10.2510","article-title":"Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates","volume":"43","author":"Oster","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.11.026_b0105","first-page":"521","article-title":"The present situation and results of the pneumococcus surveillance in Hungary as in October 2012","volume":"19","author":"National Center for Epidemiology","year":"2012","journal-title":"Epinfo"},{"key":"10.1016\/j.vaccine.2018.11.026_b0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00431-014-2408-1","article-title":"Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary","volume":"174","author":"T\u00f3thp\u00e1l","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2018.11.026_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1556\/amicr.59.2012.1.11","article-title":"Nasal carriage of Streptococcus pneumoniae among Hungarian children before the wide use of the conjugate vaccine","volume":"59","author":"T\u00f3thp\u00e1l","year":"2012","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.vaccine.2018.11.026_b0120","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis","volume":"7","author":"Spijkerman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.11.026_b0125","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1016\/j.vaccine.2011.04.004","article-title":"Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children","volume":"29","author":"Tocheva","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.11.026_b0130","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage","volume":"33","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.11.026_b0135","first-page":"362","article-title":"Pneumococcal nasopharyngeal carriage in young healthy children after pneumococcal conjugate vaccine in Turkey","volume":"34","author":"Arvas","year":"2017","journal-title":"Balkan Med J"},{"key":"10.1016\/j.vaccine.2018.11.026_b0140","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0145","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.vaccine.2017.08.020","article-title":"Pneumococcal vaccination: direct and herd effect on carriage of vaccine types and antibiotic resistance in Icelandic children","volume":"35","author":"Sigurdsson","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0150","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/molbev\/msx173","article-title":"Pneumococcal capsule synthesis locus cps as evolutionary hotspot with potential to generate novel serotypes by recombination","volume":"34","author":"Mostowy","year":"2017","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2018.11.026_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.11.026_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2334-12-69","article-title":"Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results","volume":"12","author":"Ercibengoa","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0165","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1128\/JCM.00157-11","article-title":"Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray","volume":"49","author":"Turner","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.026_b0170","doi-asserted-by":"crossref","first-page":"23809","DOI":"10.1038\/srep23809","article-title":"Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines","volume":"6","author":"Wyllie","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.11.026_b0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.113.S3.1007","article-title":"Prenatal and postnatal environmental tobacco smoke exposure and children's health","volume":"113","author":"DiFranza","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.11.026_b0180","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/clinids\/22.6.1079","article-title":"A meta-analytic review of the risk factors for acute otitis media","volume":"22","author":"Uhari","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/500935","article-title":"The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers","volume":"42","author":"Greenberg","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team","volume":"342","author":"Nuorti","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.026_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vaccine.2017.11.052","article-title":"Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9\u202fyears of pneumococcal conjugate vaccine programme","volume":"36","author":"Wouters","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.11.026_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13104-016-2353-3","article-title":"Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review","volume":"10","author":"Sugimoto","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2018.11.026_b0210","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0215","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0220","unstructured":"European Centre for Disease Prevention and Control. Invasive pneumococcal disease. In: ECDC. Annual Epidemiological Report for 2015. Stockholm. https:\/\/ecdc.europa.eu\/; 2017 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0225","first-page":"180","article-title":"Vaccine coverage of invasive and carried Streptococcus pneumoniae isolates in Hungary","volume":"24","author":"T\u00f3thp\u00e1l","year":"2014","journal-title":"LAM"},{"key":"10.1016\/j.vaccine.2018.11.026_b0230","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 \u2013 Invasive pneumococcal disease. Stockholm. http:\/\/ecdc.europa.eu\/; 2016 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1556\/amicr.59.2012.3.12","article-title":"Changes in the serotypes of Hungarian pneumococci isolated mainly from invasive infections: a review of all available data between 1988 and 2011","volume":"59","author":"T\u00f3thp\u00e1l","year":"2012","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.vaccine.2018.11.026_b0240","first-page":"14","article-title":"Streptococcus pneumoniae serotype distribution between 2013\u20132015 in Hungary","volume":"15","author":"National Center for Epidemiology","year":"2015","journal-title":"Microbiol Lett"},{"key":"10.1016\/j.vaccine.2018.11.026_b0245","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.vaccine.2017.06.047","article-title":"Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA","volume":"35","author":"McFarland","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0250","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/infdis\/jit642","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae\u2013Alaska, 2008\u20132012","volume":"209","author":"Gounder","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0255","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1016\/j.vaccine.2016.10.050","article-title":"Pneumococcal conjugate vaccine failure in children: a systematic review of the literature","volume":"34","author":"Oligbu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2017.12.035","article-title":"Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged \u22655 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008\u20132013","volume":"36","author":"Gounder","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.026_b0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","article-title":"Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance","volume":"11","author":"Farrell","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0270","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/infdis\/jir056","article-title":"The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes","volume":"203","author":"Tyrrell","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.026_b0275","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.026_b0280","unstructured":"European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe https:\/\/ecdc.europa.eu\/; 2012 [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0285","unstructured":"National Bacteriological Surveillance Management Team. NBS Annual reports. National Center for Epidemiology, Budapest, Hungary. www.oek.hu; 2015-2016 [in Hungarian] [accessed May 2018]."},{"key":"10.1016\/j.vaccine.2018.11.026_b0290","unstructured":"United States Patent Application. Immunogenic compositions comprising conjugeted capsular saccharide antigens and uses thereof. http:\/\/patents.com\/us-20150202309.html; 2015 [accessed May 2018]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:34Z","timestamp":1759400974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315494"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}